Old Web
English
Sign In
Acemap
>
authorDetail
>
Emily Frank
Emily Frank
Duke University
Lonafarnib
Farnesyltransferase inhibitor
Medicine
Pharmacokinetics
Neutropenia
2
Papers
78
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I and Pharmacokinetic Study of the Oral Farnesyltransferase Inhibitor Lonafarnib Administered Twice Daily to Pediatric Patients With Advanced Central Nervous System Tumors Using a Modified Continuous Reassessment Method: A Pediatric Brain Tumor Consortium Study
2007
Journal of Clinical Oncology
Mark W. Kieran
Roger J. Packer
Arzu Onar
Susan M. Blaney
Peter C. Phillips
Ian F. Pollack
J. Russell Geyer
S. Gururangan
Anu Banerjee
Stewart Goldman
Christopher D. Turner
Jean B. Belasco
Alberto Broniscer
Yali Zhu
Emily Frank
Paul Kirschmeier
Paul Statkevich
Antoine Yver
James M. Boyett
L. E. Kun
Show All
Source
Cite
Save
Citations (59)
Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors.
2007
Clinical Cancer Research
Neal Ready
Alan Lipton
Yali Zhu
Paul Statkevich
Emily Frank
Dolores Curtis
Ronald M. Bukowski
Show All
Source
Cite
Save
Citations (19)
1